Non-lethal inhibition of gut microbial trimethylamine production for the treatment of athero-thrombotic heart disease
Monday, January 25, 2016
4:00 pm - 5:00 pm
Stan Hazen, PhD
Duke Molecular Physiology Institute Integrative Biology Seminar Series
Sponsor(s): Duke Molecular Physiology Institute and Sarah W. Stedman Nutrition and Metabolism Center
Cost: Free
Stan Hazen, Chairman, Dept. of Cellular and Molecular Medicine, The Jan Bleeksma Chair in Vascular Cell Biology and Atherosclerosis, Lerner Research Institute, Cleveland Clinic
Contact: Kristy H. Thompson
